Mesenchymal stromal cell activation by breast cancer secretomes in bioengineered 3D microenvironments
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Mesenchymal stromal cells (MSCs) are key contributors of the tumour microenvironment and are known to promote cancer progression through reciprocal communication with cancer cells, but how they become activated is not fully understood. Here, we investigate how breast cancer cells from different stages of the metastatic cascade convert MSCs into tumour-associated MSCs (TA-MSCs) using unbiased, global approaches. Using mass spectrometry, we compared the secretomes of MCF-7 cells, invasive MDA-MB-231 cells, and sublines isolated from bone, lung, and brain metastases and identified ECM and exosome components associated with invasion and organ-specific metastasis. Next, we used synthetic hydrogels to investigate how these different secretomes activate MSCs in bioengineered 3D microenvironments. Using kinase activity profiling and RNA sequencing, we found that only MDA-MB-231 breast cancer secretomes convert MSCs into TA-MSCs, resulting in an immunomodulatory phenotype that was particularly prominent in response to bone-tropic cancer cells. We have investigated paracrine signalling from breast cancer cells to TA-MSCs in 3D, which may highlight new potential targets for anticancer therapy approaches aimed at targeting tumour stroma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many studies have con fi rmed the interaction between MSCs and breast cancer cells [44,45].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cox, T. R., Rumney, R. M. H., Schoof, E. M., Perryman, L., Høye, A. M., Agrawal, A., Bird, D., Latif, N. A., Forrest, H., Evans, H. R., et al. (2015) · Nature · doi:10.1038/nature14492 · Cited by 482
Self-citationRetractedModerated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · cited 1×
“GO analysis was performed using DAVID (version 6.8) (71) against the Homo sapiens background where terms with fold enrichment ≥ 1.5, Bonferroni-corrected P - value 0.05, EASE score (modi fi ed Fisher ’ s exact test) 0.05, and at least two proteins per keyword were considered signi fi cantly…”
InfluentialHTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 1×
“A high aerobic glycolytic activity is a hallmark of cancer and is known as the Warburg effect in cancer cells (44, 45).”
Macrophage plasticity, polarization, and function in health and disease
Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930
Warde-Farley, D., Donaldson, S. L., Comes, O., Zuberi, K., Badrawi, R., Chao, P., Franz, M., Grouios, C., Kazi, F., Lopes, C. T., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq537 · Cited by 4,835
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Lutolf, M. P., & Hubbell, J. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1055 · Cited by 4,551 · cited 1×
“In contrast, synthetic hydrogels are a useful alternative when focusing on cell signalling events as they are generated with de fi ned biochemical and biophysical properties and are free of confounding ECM or signalling proteins that are present in ECM-derived hydrogels (21, 22, 23).”
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715 · cited 1×
“TA-MSCs assist cancer progression by promoting metastasis, tumour vascularisation, and immunosuppressive conditions (7, 8, 9, 10, 11).”
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206 · cited 1×
“show to promote breast cancer cell malignancy (12, 13, 14) and”
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991 · cited 1×
“Clustered data were visualized using Java TreeView (82).”
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“These MDA-MB-231 sublines have been generated by repeated, organ-tropic in vivo selection of MDA-MB-231 cells that had been injected to the left ventricle of nude mice (28, 29, 30, 31, 32).”
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597 · cited 1×
“These MDA-MB-231 sublines have been generated by repeated, organ-tropic in vivo selection of MDA-MB-231 cells that had been injected to the left ventricle of nude mice (28, 29, 30, 31, 32).”
MethodIntegration of biological networks and gene expression data using Cytoscape
Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., Avila-Campilo, I., Creech, M., Gross, B., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.324 · Cited by 2,507 · cited 1×
“0) (84) where enriched proteins were mapped onto a human interactome consisting of reported physical protein–protein interactions.”
Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., & Shi, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.11.014 · Cited by 2,101 · cited 1×
“TA-MSCs assist cancer progression by promoting metastasis, tumour vascularisation, and immunosuppressive conditions (7, 8, 9, 10, 11).”
A practical guide to hydrogels for cell culture
Caliari, S. R., & Burdick, J. A. (2016) · Nature Methods · doi:10.1038/nmeth.3839 · Cited by 2,075
Galaxy: A platform for interactive large-scale genome analysis
Giardine, B., Riemer, C., Hardison, R. C., Burhans, R., Elnitski, L., Shah, P., Zhang, Y., Blankenberg, D., Albert, I., Taylor, J., et al. (2005) · Genome Research · doi:10.1101/gr.4086505 · Cited by 2,026
AmiGO: online access to ontology and annotation data
Carbon, S., Ireland, A., Mungall, C. J., Shu, S., Marshall, B., Lewis, S., Hub, T. A., & the Web Presence Working Group (2009) · Bioinformatics · doi:10.1093/bioinformatics/btn615 · Cited by 1,952 · cited 1×
“Exosome components were extracted based on the H. sapiens extracellular exosome GO annotation in AmiGO (version 2.5.12) ( 72).”
InfluentialDesigning Cell-Compatible Hydrogels for Biomedical Applications
Seliktar, D. (2012) · Science · doi:10.1126/science.1214804 · Cited by 1,923 · cited 1×
“In contrast, synthetic hydrogels are a useful alternative when focusing on cell signalling events as they are generated with de fi ned biochemical and biophysical properties and are free of confounding ECM or signalling proteins that are present in ECM-derived hydrogels (21, 22, 23).”
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
Vizcaíno, J. A., Côté, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1262 · Cited by 1,918
Genes that mediate breast cancer metastasis to the brain
Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863 · cited 1×
“These MDA-MB-231 sub-lines have been generated by repeated, organ-tropic in vivo selection of MDA-MB-231 cells that had been injected to the left ventricle of nude mice (28, 29, 30, 31, 32).”
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862 · cited 1×
“The lack of change of the MDA-Brain secretome compared with the MDA-WT might be linked to these cells crossing the blood–brain barrier, which then blocks factors in the circulation (36), such as secreted molecules and exosomes released by the primary tumour, reaching”
Naba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., & Hynes, R. O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014647 · Cited by 1,354 · cited 1×
“proteins reported in the humanmatrisome database (33) and found that 23 ECM proteins were higher in the MDA-WT secretome, whereas only five were higher in the MCF-7 secretome (Fig 1D), which could be attributed to the different EMT statuses that MDAWT and MCF-7 have.”
BackgroundCancer to bone: a fatal attraction
Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3055 · Cited by 1,285 · cited 1×
“In particular, breast cancer cells often invade surrounding primary site stroma, enter the vasculature or lymphatic system, and metastasise to secondary organs, leading to worse clinical outcomes for patients (1).”
Daigneault, M., Preston, J. A., Marriott, H. M., Whyte, M. K. B., & Dockrell, D. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008668 · Cited by 1,151 · cited 1×
“To test whether TA-MSCs drive also the activation of macrophages, we generated naı̈ve macrophages from the human monocyte THP-1 cell line as described previously (52) and treated them with either the breast cancer secretomes directly or with CM obtained from MSCs that were themselves pretreated with the breast cancer…”
Targeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084 · cited 1×
“contribute to cancer cell resistance to chemotherapy (15).”
Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S. W., Takashi, S., Baik, G. H., Shibata, W., DiPrete, B., Betz, K. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.020 · Cited by 1,044 · cited 1×
“Tumour-associated mesenchymal stromal cells (TA-MSCs) are a major component of the TME and are a potential source of cancer-associated fi broblasts (CAFs) (3, 4, 5, 6).”
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn, A. J., Kang, Y., Serganova, I. S., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R. G., & Massagué, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522320 · Cited by 742 · cited 1×
“These MDA-MB-231 sublines have been generated by repeated, organ-tropic in vivo selection of MDA-MB-231 cells that had been injected to the left ventricle of nude mice (28, 29, 30, 31, 32).”
MethodPerseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research
Tyanova, S., & Cox, J. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7493-1_7 · Cited by 661 · cited 1×
“cancer cell secretomes analysed, and any missing values were imputed in the Perseus software package (69), using the normal distribution with a width set to 0.”
Organoids: A historical perspective of thinking in three dimensions
Simian, M., & Bissell, M. J. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610056 · Cited by 620 · cited 15×
“To provide an overview of potential new matrisome interactions in the TME upon TA-MSC activation, we generated protein – protein interaction network models of matrisome proteins enriched in the MDA-WT secretome and transcripts induced in MSCs by the MDA-WT secretome (Figs 5B and S6B).”
InfluentialTAMeless traitors: macrophages in cancer progression and metastasis
Aras, S., & Zaidi, M. R. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.356 · Cited by 609
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602 · cited 1×
“Our work on the molecular profiling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., De Donatis, A., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 578
Horton, E. R., Byron, A., Askari, J. A., Ng, D. H. J., Millon-Frémillon, A., Robertson, J., Koper, E. J., Paul, N. R., Warwood, S., Knight, D., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3257 · Cited by 543 · cited 1×
“Functional enrichment maps were generated as described previously (78, 79).”
MethodSelf-citationBone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
Eckert, M. A., Coscia, F., Chryplewicz, A., Chang, J. W., Hernandez, K. M., Pan, S., Tienda, S. M., Nahotko, D. A., Li, G., Blaženović, I., et al. (2019) · Nature · doi:10.1038/s41586-019-1173-8 · Cited by 503 · cited 1×
“In support of a possible function of COMP in metastasis, COMP has been shown to promote lung metastasis of breast cancer and has been found to be the most up-regulated protein in stromal cells at sites of metastases versus primary tumours in ovarian cancer (47, 48).”
A history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0006-7 · Cited by 502 · cited 14×
“To provide an overview of potential new matrisome interactions in the TME upon TA-MSC activation, we generated protein – protein interaction network models of matrisome proteins enriched in the MDA-WT secretome and transcripts induced in MSCs by the MDA-WT secretome (Figs 5B and S6B).”
InfluentialYoneda, T., Williams, P. J., Hiraga, T., Niewolna, M., & Nishimura, R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1486 · Cited by 473 · cited 1×
“These MDA-MB-231 sub-lines have been generated by repeated, organ-tropic in vivo selection of MDA-MB-231 cells that had been injected to the left ventricle of nude mice (28, 29, 30, 31, 32).”
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Shi, Y., Du, L., Lin, L., & Wang, Y. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.193 · Cited by 460 · cited 1×
“targets for novel anticancer therapies (16).”
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
Jung, Y., Kim, J. K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., Berry, J. E., McGee, S., Lee, E., Sun, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2766 · Cited by 423 · cited 1×
“TA-MSCs assist cancer progression by promoting metastasis, tumour vascularisation, and immunosuppressive conditions (7, 8, 9, 10, 11).”
Riedl, A., Schlederer, M., Pudelko, K., Stadler, M., Walter, S., Unterleuthner, D., Unger, C., Kramer, N., Hengstschläger, M., Kenner, L., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.188102 · Cited by 389 · cited 15×
“MSC activation by cancer secretomes in bioengineered 3D microenvironments To resemble the characteristics of the TME under physiologically relevant and highly controlled in vitro conditions, we engineered fully defined 3D microenvironments using PEG hydrogels (Fig 2A).”
BackgroundInfluentialExtracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A., & Hynes, R. O. (2014) · eLife · doi:10.7554/elife.01308 · Cited by 377 · cited 1×
“comparing the matrsiome of MDA-WT and MDA-Lung tumour xenografts (63), MMP1 and THBS2 were detected uniquely in MDA-WT tumours and AGRN was detected uniquely in MDA-Lung tumours, which correlates with our proteomics data of MDA-WT and MDALung secretomes.”
ResultRen, G., Zhao, X., Wang, Y., Zhang, X., Chen, X., Xu, C., Yuan, Z.-R., Roberts, A. I., Zhang, L., Zheng, B., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.08.013 · Cited by 361 · cited 3×
“Macrophages are a further key component of the TME and have been shown to be recruited by TA-MSCs (41, 50, 51).”
Biomolecular Hydrogels Formed and Degraded via Site-Specific Enzymatic Reactions
Ehrbar, M., Rizzi, S. C., Schoenmakers, R. G., San Miguel, B., Hubbell, J. A., Weber, F. E., & Lutolf, M. P. (2007) · Biomacromolecules · doi:10.1021/bm070228f · Cited by 299 · cited 2×
“We have previously developed cytocompatible enzymatically cross-linked poly ethylene glycol (PEG) hydrogels that are matrix metalloproteinase (MMP)-degradable and contain the cell adhesion site arginylglycylaspartic acid (RGD), thereby providing ECM-mimicking microenvironments (24, 25).”
Self-citationEph Receptors and Ephrins: Therapeutic Opportunities
Barquilla, A., & Pasquale, E. B. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140226 · Cited by 294
Zeeberg, B. R., Qin, H., Narasimhan, S., Sunshine, M., Cao, H., Kane, D. W., Reimers, M., Stephens, R. M., Bryant, D., Burt, S. K., et al. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-168 · Cited by 279 · cited 1×
“Overrepresentation of GO terms was calculated for the list of signi fi cantly altered genes using High-Throughput GoMiner (80) using the H. sapiens background.”
Chowdhury, R., Webber, J. P., Gurney, M., Mason, M. D., Tabi, Z., & Clayton, A. (2015) · Oncotarget · doi:10.18632/oncotarget.2711 · Cited by 272 · cited 1×
“Furthermore, the metal-loendopeptidase activity term (MMP1, MMP3, MMP8, MMP9, and MMP13) indicates a matrix-remodelling phenotype of MSCs, which expands earlier fi ndings on the induced proteolytical and thereby promigratory activity of TA-MSCs/CAFs (41, 42).”
Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering
Ehrbar, M., Rizzi, S. C., Hlushchuk, R., Djonov, V., Zisch, A. H., Hubbell, J. A., Weber, F. E., & Lutolf, M. P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.027 · Cited by 233 · cited 4×
“Hydrogel volume was 50 μ l. Subsequently, PEG cross-linking was initiated by addition of 10 U ml − 1 FXIIIa and disc-shaped matrices were prepared between hydrophobic glass slides (treated with SigmaCote; Sigma-Aldrich).”
InfluentialSelf-citationCharacterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics
Naba, A., Pearce, O. M. T., Del Rosario, A., Ma, D., Ding, H., Rajeeve, V., Cutillas, P. R., Balkwill, F. R., & Hynes, R. O. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00191 · Cited by 228
Mesenchymal stem cells promote growth and angiogenesis of tumors in mice
Huang, W.-H., Chang, M.-C., Tsai, K.-S., Hung, M.-C., Chen, H.-L., & Hung, S.-C. (2013) · Oncogene · doi:10.1038/onc.2012.458 · Cited by 227 · cited 1×
“TA-MSCs assist cancer progression by promoting metastasis, tumour vascularisation, and immunosuppressive conditions (7, 8, 9, 10, 11).”
Weber, C. E., Kothari, A. N., Wai, P. Y., Li, N. Y., Driver, J., Zapf, M. A. C., Franzen, C. A., Gupta, G. N., Osipo, C., Zlobin, A., et al. (2015) · Oncogene · doi:10.1038/onc.2014.410 · Cited by 226
Yu, P. F., Huang, Y., Han, Y. Y., Lin, L. Y., Sun, W. H., Rabson, A. B., Wang, Y., & Shi, Y. F. (2017) · Oncogene · doi:10.1038/onc.2016.217 · Cited by 225 · cited 1×
“TA-MSCs have been show to promote breast cancer cell malignancy (12, 13, 14) and contribute to cancer cell resistance to chemotherapy (15).”
YAP-independent mechanotransduction drives breast cancer progression
Lee, J. Y., Chang, J. K., Dominguez, A. A., Lee, H.-P., Nam, S., Chang, J., Varma, S., Qi, L. S., West, R. B., & Chaudhuri, O. (2019) · Nature Communications · doi:10.1038/s41467-019-09755-0 · Cited by 199 · cited 15×
“To provide an overview of potential new matrisome interactions in the TME upon TA-MSC activation, we generated protein – protein interaction network models of matrisome proteins enriched in the MDA-WT secretome and transcripts induced in MSCs by the MDA-WT secretome (Figs 5B and S6B).”
InfluentialBray, L. J., Binner, M., Holzheu, A., Friedrichs, J., Freudenberg, U., Hutmacher, D. W., & Werner, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.124 · Cited by 197 · cited 1×
“Our work on the molecular profiling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
MethodMayorca-Guiliani, A. E., Madsen, C. D., Cox, T. R., Horton, E. R., Venning, F. A., & Erler, J. T. (2017) · Nature Medicine · doi:10.1038/nm.4352 · Cited by 177 · cited 1×
“Functional enrichment maps were generated as described previously (78, 79).”
Self-citationThe role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model
Liu, H., Kato, Y., Erzinger, S. A., Kiriakova, G. M., Qian, Y., Palmieri, D., Steeg, P. S., & Price, J. E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-583 · Cited by 172 · cited 1×
“are both ECM regulatory enzymes known to be involved in breast cancer and metastasis (34, 35).”
Gill, B. J., Gibbons, D. L., Roudsari, L. C., Saik, J. E., Rizvi, Z. H., Roybal, J. D., Kurie, J. M., & West, J. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0895 · Cited by 170
3D scaffolds in breast cancer research
Rijal, G., & Li, W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.016 · Cited by 169 · cited 1×
“It has been shown that cell signalling and drug responses differ when cells are cultured on rigid 2D substrates or using 3D cell culture systems that more closely mimic the TME (17, 18, 19, 20).”
Luo, J., Lee, S., Liang, L., Huang, C.-K., Li, L., Wen, S., & Chang, C. (2013) · Oncogene · doi:10.1038/onc.2013.233 · Cited by 162 · cited 1×
“TA-MSCs assist cancer progression by promoting metastasis, tumour vascularisation, and immunosuppressive conditions (7, 8, 9, 10, 11).”
Taubenberger, A. V., Bray, L. J., Haller, B., Shaposhnykov, A., Binner, M., Freudenberg, U., Guck, J., & Werner, C. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.03.017 · Cited by 139 · cited 1×
“Our work on the molecular pro fi ling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
Preactivation of Human MSCs with TNF-α Enhances Tumor-Suppressive Activity
Lee, R. H., Yoon, N., Reneau, J. C., & Prockop, D. J. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.10.001 · Cited by 127 · cited 1×
“Macrophages are a further key component of the TME and have been shown to be recruited by TA-MSCs (41, 50, 51).”
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
Englund, E., Bartoschek, M., Reitsma, B., Jacobsson, L., Escudero‐Esparza, A., Orimo, A., Leandersson, K., Hagerling, C., Aspberg, A., Storm, P., et al. (2016) · Oncogene · doi:10.1038/onc.2016.98 · Cited by 125
Papadimitropoulos, A., Piccinini, E., Brachat, S., Braccini, A., Wendt, D. J., Barbero, A., Jacobi, C., & Martín, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102359 · Cited by 112
Ishihara, S., Inman, D. R., Li, W.-J., Ponik, S. M., & Keely, P. J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0569 · Cited by 96 · cited 1×
“which increases breast cancer proliferation (43).”
Singh, S. P., Schwartz, M. P., Lee, J. Y., Fairbanks, B. D., & Anseth, K. S. (2014) · Biomaterials Science · doi:10.1039/c4bm00022f · Cited by 92 · cited 1×
“Our work on the molecular pro fi ling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities
Lin, L., Du, L., Cao, K., Huang, Y., Yu, P., Zhang, L. Y., Li, F. Y., Wang, Y., & Shi, Y. (2016) · Oncogene · doi:10.1038/onc.2016.131 · Cited by 91
Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis
Yu, P. F., Huang, Y., Xu, C. L., Lin, L. Y., Han, Y. Y., Sun, W. H., Hu, G. H., Rabson, A. B., Wang, Y., & Shi, Y. F. (2017) · Oncogene · doi:10.1038/onc.2016.252 · Cited by 88 · cited 1×
“TA-MSCs have been show to promote breast cancer cell malignancy (12, 13, 14) and contribute to cancer cell resistance to chemotherapy (15).”
Bioinspired Hydrogels to Engineer Cancer Microenvironments
Park, K. M., Lewis, D., & Gerecht, S. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044619 · Cited by 83 · cited 1×
“Our work on the molecular profiling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
Fisher, S. A., Tam, R. Y., Fokina, A., Mahmoodi, M. M., Distefano, M. D., & Shoichet, M. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.032 · Cited by 78 · cited 1×
“Our work on the molecular pro fi ling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
Blache, U., Metzger, S., Vallmajó-Martín, Q., Martín, I., Djonov, V., & Ehrbar, M. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500795 · Cited by 76 · cited 1×
“and can closely mimic their niches (26, 27).”
Self-citationProfiling Activity of Cellular Kinases in Migrating T-Cells
Chirumamilla, C. S., Fazil, M. H. U. T., Perez-Novo, C. A., Rangarajan, S., de Wijn, R., Ramireddy, P., Verma, N. K., & Berghe, W. V. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9036-8_13 · Cited by 61
Ferroni, P., Roselli, M., Portarena, I., Formica, V., Riondino, S., Farina, F., Costarelli, L., Melino, A., Massimiani, G., Cavaliere, F., et al. (2014) · PubMed · Cited by 58
Brantley‐Sieders, D. M. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.10.014 · Cited by 57 · cited 1×
“The most signi fi cantly and intensely changed PTKs are type A ephrin receptors (EPHA1, EPHA3, EPHA4, and EPHA8), which are known to be involved in cancer and angiogenesis (38, 39).”
Notch‐inducing hydrogels reveal a perivascular switch of mesenchymal stem cell fate
Blache, U., Vallmajó-Martín, Q., Horton, E. R., Guerrero, J., Djonov, V., Scherberich, A., Erler, J. T., Martín, I., Snedeker, J. G., Milleret, V., et al. (2018) · EMBO Reports · doi:10.15252/embr.201845964 · Cited by 52 · cited 2×
“7% wt/vol (corresponding to a storage modulus of 470 Pa (27)) were prepared by stoichiometrically balanced ([Lys]/[Gln] = 1) precursor solutions of n-PEG-Gln and n-PEG-MMP-sensitive-Lys (previously described (24, 25)) in 50 mM Tris buffer, pH 7.”
Self-citationBray, L. J., Secker, C., Murekatete, B., Sievers, J., Binner, M., Welzel, P. B., & Werner, C. (2018) · Cancers · doi:10.3390/cancers10090292 · Cited by 40 · cited 1×
“Our work on the molecular profiling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
Chocry, M., Leloup, L., & Kovacic, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21780 · Cited by 37
Macdougall, L. J., Wiley, K. L., Kloxin, A. M., & Dove, A. P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.046 · Cited by 31 · cited 1×
“Our work on the molecular pro fi ling of TA-MSC activation complements previous work using PEG hydrogels for the study of tumour morphogenesis, drug responses, and cell invasion (54, 55, 56, 57, 58, 59, 60, 61, 62).”
Predicting gene regulation by sigma factors in Bacillus subtilis from genome-wide data
de Hoon, M., Makita, Y., Imoto, S., Kobayashi, K., Ogasawara, N., Nakai, K., & Miyano, S. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth927 · Cited by 26
Proteomic Characterization of Caenorhabditis elegans Larval Development
Xia, T., Horton, E. R., Salcini, A. E., Pocock, R., Cox, T. R., & Erler, J. T. (2017) · PROTEOMICS · doi:10.1002/pmic.201700238 · Cited by 10 · cited 1×
“To identify proteins expressed uniquely in one secretome or another, we classified proteins as present in a secretome, provided label-free quantitation intensity values were greater than zero in at least two biological replicates, and we classified proteins as not expressed in a secretome if the intensity value was eq…”
MethodSelf-citation
Cited by
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
Engineered hydrogels for mechanobiology
Blache, U., Ford, E. M., Ha, B., Rijns, L., Chaudhuri, O., Dankers, P. Y. W., Kloxin, A. M., Snedeker, J. G., & Gentleman, E. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00179-7 · Cited by 227
Self-citationHill, B. S., Sarnella, A., D’Avino, G., & Zannetti, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.028 · Cited by 156
Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy
Zhang, F., Guo, J., Zhang, Z., Qian, Y., Wang, G., Duan, M., Zhao, H., Yang, Z., & Jiang, X. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.11.015 · Cited by 127
Nielsen, S. R., Strøbech, J. E., Horton, E. R., Jackstadt, R., Laitala, A., Bravo, M. C., Maltese, G., Jensen, A. R. D., Reuten, R., Rafaeva, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23731-7 · Cited by 125
Self-citation
Metadata
- Authors
- Blache, U., Horton, E. R., Xia, T., Schoof, E. M., Blicher, L. H., Schönenberger, A., Snedeker, J. G., Martin, I., Erler, J. T., & Ehrbar, M.
- Affiliations
- University of Zurich (CH)
- University of Copenhagen (DK)
- Technical University of Denmark (DK)
- Institute for Biomechanics, Eidgenössische Technische Hochschule Zurich, Zurich, Switzerland
- Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland
- Corresponding author
- Erler, Janine T
- Ehrbar, Martin
- Venue
- Life Science Alliance
- Publisher
- Life Science Alliance, LLC
- Published
- 2019-06
- Volume
- 2
- Issue
- 3
- Pages
- e201900304
- ISSN
- 2575-1077 (ISSN-L)
- PMC
- PMC6549139
- OpenAlex
- W2948778357
- Cited by
- 49
- References
- 86
- Citations by year
- 2026: 3 · 2024: 4 · 2023: 5 · 2022: 15 · 2021: 12 · 2020: 7 · 2019: 1
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life Science Alliance (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, cc-by)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- ETH Zürich Research Collection (cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Research Council (ERC-2015-CoG-682881-MATRICAN)
- European Molecular Biology Organization (ATLF 922-2016)
- Danish Cancer Society (R204-A12445)
- European Union's Seventh Framework Programme (607868)
- Swiss National Science Foundation (310030-169808/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- mesenchymal stem cells, breast cancer, secretome, paracrine signaling, 3D microenvironment, synthetic hydrogels, exosomes, extracellular matrix, organ-specific metastasis, bone metastasis, immunomodulation, MDA-MB-231 cells, MCF-7 cells, tumor microenvironment, tumor stroma
- MeSH terms
- Breast Neoplasms, Chromatography, Liquid, Female, Humans, Mass Spectrometry, Tumor Cells, Cultured, Biomarkers, Cell Culture Techniques, Proteome, Gene Expression Profiling, Proteomics, Cell Line, Tumor, Metabolomics, Metabolome, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.